SEC Form 10-Q filed by enGene Holdings Inc. - Quantisnow

enGene Holdings Inc. announced Raj Pruthi MD MHA FACS as SVP, Urologic Oncology and Clinical Development, supporting EG-70's clinical development for BCG-unresponsive NMIBC.